Antisense oligonucleotide industry sales are expected to rise at a Compound Annual Growth Rate (CAGR) of 6.6% over the course of the projection period, indicating the market’s tremendous potential. It is predicted to generate over US$ 5,519.6 million in income by 2033, a remarkable increase from US$ 2,913.5 million in 2023. Unveiling therapeutic potential, …
Continue reading “Antisense Oligonucleotides Industry Poised to Reach US$ 5,519.6 Million by 2033”